Skip Navigation

VAERS Bibliography - February 2005

  1. Polio Vaccination Campaign Reaches Over 95% of Children Under Five in Iraq.   Ann Saudi Med; 24 (6): 492; November, 2004.

  2. Largest Ever Polio Vaccination Campaign.   Bull World Health Organ; 82 (11): 890; November, 2004.

  3. Two Countries Re-Infected With Polio, As Nigerian State Resumes Vaccinations.   Bull World Health Organ; 82 (9): 717; September, 2004.

  4. Diphtheria, Tetanus and Pertussis Vaccine.   Nurs Times; 100 (47): 35; November 23, 2004.

  5. Establishment of Vaccination Clinics; User Fees for Investigational New Drug (IND) Influenza Vaccine Services and Vaccines. Interim Final Rule and Request for Comments.   Fed Regist; 70 (15): 3490-3493; January 25, 2005.

  6. [Mass Vaccination Campaign Against Serogroup C Meningococcal Disease, Municipality of Itapeva, Sao Paulo.].   Rev Saude Publica; 39 (1): 139-140; January, 2005.

  7. HHS-CDC NEWS: Recommended Childhood and Adolescent Immunization Schedule--US, 2005.   Ann Pharmacother; 39 (2): 396; February, 2005.

  8. Recommended Childhood and Adolescent Immunization Schedule: United States, 2005.   Pediatrics; 115 (1): 182; January, 2005.

  9. Andrade, A. L.; Martelli, C. M.  Globalisation of Hib Vaccination--How Far Are We?   Lancet; 365 (9453): 5-7; January 1, 2005.

  10. Angoulvant, F.; Bidet, P.; Doit, C.; Aubertin, G.; Soussan, V.; Bingen, E.; Bourrillon, A.; Faye, A.  Serotype 6B Pneumococcal Meningitis in an Immunocompetent Infant Immunized With Heptavalent Pneumococcal Conjugated Vaccine.   Clin Infect Dis; 40 (3): 494-495; February 1, 2005.

  11. Baltimore, R. S.; Jenson, H. B.  The Immunization Schedule Confronts Adolescence.   Curr Opin Pediatr; 17 (1): 54-55; February, 2005.

  12. Barker, L. E.; Smith, P. J.; Gerzoff, R. B.; Luman, E. T.; McCauley, M. M.; Strine, T. W.  Ranking States' Immunization Coverage: an Example From the National Immunization Survey.   Stat Med; 24 (4): 605-613; January 28, 2005.

  13. Batt, K.; Fox-Rushby, J. A.; Castillo-Riquelme, M.  The Costs, Effects and Cost-Effectiveness of Strategies to Increase Coverage of Routine Immunizations in Low- and Middle-Income Countries: Systematic Review of the Grey Literature.   Bull World Health Organ; 82 (9): 689-696; September, 2004.

  14. Bennett, D. A.; Holtzman, D. M.  Immunization Therapy for Alzheimer Disease?   Neurology; 64 (1): 10-12; January 11, 2005.

  15. Bergeron, B.  To Vaccinate or Not to Vaccinate: Rubella and the Adult Woman.   Midwifery Today Int Midwife; 72: 48-49; Winter 2004.

  16. Bernsen, R. M.; van der Wouden, J. C.  Re: No Epidemiological Evidence for Infant Vaccinations to Cause Allergic Disease.  Vaccine; 23 (12): 1427; February 10, 2005.

  17. Bogaert, D.; Veenhoven, R. H.; Sluijter, M.; Wannet, W. J.; Rijkers, G. T.; Mitchell, T. J.; Clarke, S. C.; Goessens, W. H.; Schilder, A. G.; Sanders, E. A.; de, Groot R.; Hermans, P. W.  Molecular Epidemiology of Pneumococcal Colonization in Response to Pneumococcal Conjugate Vaccination in Children With Recurrent Acute Otitis Media.   J Clin Microbiol; 43 (1): 74-83; January, 2005.

  18. Brydak, L. B.; Tadeusz, S.; Magdalena, M.  Antibody Response to Influenza Vaccination in Healthy Adults.   Viral Immunol; 17 (4): 609-615; 2004.

  19. Bueving, H. J.; Thomas, S.; Wouden, J. C.  Is Influenza Vaccination in Asthma Helpful?   Curr Opin Allergy Clin Immunol; 5 (1): 65-70; February, 2005.

  20. Chen, C. S.; Liu, T. C.  The Taiwan National Health Insurance Program and Full Infant Immunization Coverage.   Am J Public Health; 95 (2): 305-311; February, 2005.

  21. Crowe, S. R.; Miller, S. C.; Shenyo, R. M.; Woodland, D. L.  Vaccination With an Acidic Polymerase Epitope of Influenza Virus Elicits a Potent Antiviral T Cell Response but Delayed Clearance of an Influenza Virus Challenge.   J Immunol; 174 (2): 696-701; January 15, 2005.

  22. Cunha, S. S.; Camacho, L. A.; Santos, A. C.; Dourado, I.  Influenza Vaccination in Brazil: Rationale and Caveats.   Rev Saude Publica; 39 (1): 129-136; January, 2005.

  23. Dietz, V.; Venczel, L.; Izurieta, H.; Stroh, G.; Zell, E. R.; Monterroso, E.; Tambini, G.  Assessing and Monitoring Vaccination Coverage Levels: Lessons From the Americas.   Rev Panam Salud Publica; 16 (6): 432-442; December, 2004. VAERS

  24. Eggertson, L.  Vaccinating the World: How Likely?   CMAJ; 172 (1): 24; January 4, 2005.

  25. Fox-Rushby, J. A.; Kaddar, M.; Levine, R.; Brenzel, L.  The Economics of Vaccination in Low- and Middle-Income Countries.   Bull World Health Organ; 82 (9): 640; September, 2004.

  26. Francisco, P. M.; Donalisio, M. R.; Lattorre, Mdo R.  [Impact of Influenza Vaccination on Mortality by Respiratory Diseases Among Brazilian Elderly Persons.].   Rev Saude Publica; 39 (1): 75-81; January, 2005.

  27. Gami, A. S.; Murphy, J.; Cooper, L. T., Jr.  Cautious Interpretation of Data Regarding Myopericarditis Associated With Smallpox Vaccination.   J Am Coll Cardiol; 45 (1): 160-161; January 4, 2005.

  28. Gershon, A.  Contagiousness of Varicella in Vaccinated Cases: A Household Contact Study.   J Pediatr; 146 (1): 147; January, 2005.

  29. Griffiths, U. K.; Wolfson, L. J.; Quddus, A.; Younus, M.; Hafiz, R. A.  Incremental Cost-Effectiveness of Supplementary Immunization Activities to Prevent Neonatal Tetanus in Pakistan.   Bull World Health Organ; 82 (9): 643-651; September, 2004.

  30. Gulati, U.; Kumari, K.; Wu, W.; Keitel, W. A.; Air, G. M.  Amount and Avidity of Serum Antibodies Against Native Glycoproteins and Denatured Virus After Repeated Influenza Whole-Virus Vaccination. Vaccine; 23 (11): 1414-1425; February 3, 2005.

  31. Hill, T.; Platzer, A.; Reyes, C.  Influenza Deaths in Spite of Immunization and Prophylaxis.   Clin Infect Dis; 40 (3): 492-493; February 1, 2005.

  32. Kaddar, M.; Lydon, P.; Levine, R.  Financial Challenges of Immunization: a Look at GAVI.   Bull World Health Organ; 82 (9): 697-702; September, 2004.

  33. Kanra, G.; Isik, P.; Kara, A.; Cengiz, A. B.; Secmeer, G.; Ceyhan, M.  Complementary Findings in Clinical and Epidemiologic Features of Mumps and Mumps Meningoencephalitis in Children Without Mumps Vaccination.   Pediatr Int; 46 (6): 663-668; December, 2004.

  34. Kempe, A.; Daley, M. F.; Barrow, J.; Allred, N.; Hester, N.; Beaty, B. L.; Crane, L. A.; Pearson, K.; Berman, S.  Implementation of Universal Influenza Immunization Recommendations for Healthy Young Children: Results of a Randomized, Controlled Trial With Registry-Based Recall.   Pediatrics; 115 (1): 146-154; January, 2005.

  35. Khan, M. M.; Khan, S. H.; Walker, D.; Fox-Rushby, J.; Cutts, F.; Akramuzzaman, S. M.  Cost of Delivering Child Immunization Services in Urban Bangladesh: a Study Based on Facility-Level Surveys.   J Health Popul Nutr; 22 (4): 404-412; December, 2004.

  36. Kuno-Sakai, H.; Kimura, M.  Safety and Efficacy of Acellular Pertussis Vaccine in Japan, Evaluated by 23 Years of Its Use for Routine Immunization.   Pediatr Int; 46 (6): 650-655; December, 2004.

  37. Lalosevic, D.; Lalosevic, V.; Saric, M.; Mazibrada, J.; Babovic, S.; Sekulic, S.; Mitic, Z.  [Fatal Outcome After Postexposure Rabies Vaccination in a Patient With Parkinson's Disease].   Med Pregl; 57 (9-10): 487-492; September, 2004.

  38. Leibovitz, E.; Jacobs, M. R.; Dagan, R.  Haemophilus Influenzae: a Significant Pathogen in Acute Otitis Media.   Pediatr Infect Dis J; 23 (12): 1142-1152; December, 2004.

  39. Lepine, P.  [Evolution of Rabies Vaccination].   Bull Acad Natl Med; 163 (3): 265-271; March, 1979.

  40. Malmvall, B. E.; Abom, P. E.  [Influenza Vaccination for All Older Than 65 Years--Utopia or Possibility].   Lakartidningen; 101 (51-52): 4196-1; December 23, 2004.

  41. Mande, R.  [Rubella Immunization].   Bull Acad Natl Med; 163 (3): 272-276; March, 1979.

  42. McMahon, A. W.; Bryant-Genevier, M. C.; Woo, E. J.; Braun, M. M.; Ball, R.  Photophobia Following Smallpox Vaccination.   Vaccine; 23 (9): 1097-1098; January, 2005. VAERS

  43. Mercier, P.; Antoine, H. M.  [Should Typhoid-Paratyphoid Vaccination Be Continued?].   Bull Acad Natl Med; 163 (5): 446-450; May, 1979.

  44. Mohan, P.  Inequities in Coverage of Preventive Child Health Interventions: the Rural Drinking Water Supply Program and the Universal Immunization Program in Rajasthan, India.   Am J Public Health; 95 (2): 241-244; February, 2005.

  45. Muller, D.; Wutzler, P.; Szucs, T. D.  Influenza Vaccination Coverage Rates in Germany A Population-Based Cross-Sectional Analysis of the Seasons 2002/2003 and 2003/2004.   Med Klin (Munich); 100 (1): 6-13; January, 2005.

  46. Ovsyannikova, I. G.; Jacobson, R. M.; Vierkant, R. A.; Jacobsen, S. J.; Pankratz, V. S.; Poland, G. A.  Human Leukocyte Antigen Class II Alleles and Rubella-Specific Humoral and Cell-Mediated Immunity Following Measles-Mumps-Rubella-II Vaccination.   J Infect Dis; 191 (4): 515-519; February 15, 2005.

  47. Palenik, C. J.; Govoni, M.  An Immunization Program for Dental Practices.   Compend Contin Educ Dent; 25 (1 Suppl): 17-22; January, 2004.

  48. Pallasch, G.; Salman, R.; Hartwig, C.  [Improvement of Protection Given by Vaccination for Socially Underprivileged Groups on the Basis of "Key Persons Approach" - Results of an Intervention Based on Cultural and Language Aspects for Children of Immigrants in Altlander Viertel Provided by the Health Department of Stade.]. Gesundheitswesen; 67 (1): 33-38; January, 2005.

  49. Papadouka, V.; Schaeffer, P.; Metroka, A.; Borthwick, A.; Tehranifar, P.; Leighton, J.; Aponte, A.; Liao, R.; Ternier, A.; Friedman, S.; Arzt, N.  Integrating the New York Citywide Immunization Registry and the Childhood Blood Lead Registry.   J Public Health Manag Pract; Suppl: S72-S80; November, 2004.

  50. Pei, H.; Liu, J.; Cheng, Y.; Sun, C.; Wang, C.; Lu, Y.; Ding, J.; Zhou, J.; Xiang, H.  Expression of SARS-Coronavirus Nucleocapsid Protein in Escherichia Coli and Lactococcus Lactis for Serodiagnosis and Mucosal Vaccination.   Appl Microbiol Biotechnol; January, 2005. [Epub ahead of print]

  51. Prevots, D. R.; Pascual, F. B.; Angellili, M. L.; Brayden, R.; Irigoyen, M.; Larussa, P.; Sawyer, M.; Baughman, A. L.; Pallansch, M. A.  Population Immunity to Polioviruses Among Preschool Children From Four Urban Underserved Low Income Communities, United States, 1997-2001.   Pediatr Infect Dis J; 23 (12): 1130-1136; December, 2004.

  52. Rothberg, M. B.; Rose, D. N.  Vaccination Versus Treatment of Influenza in Working Adults: a Cost-Effectiveness Analysis.   Am J Med; 118 (1): 68-77; January, 2005.

  53. Saarlas, K. N.; Hinman, A. R.; Ross, D. A.; Watson, W. C., Jr.; Wild, E. L.; Hastings, T. M.; Richmond, P. A.  All Kids Count 1991-2004: Developing Information Systems to Improve Child Health and the Delivery of Immunizations and Preventive Services.   J Public Health Manag Pract; Suppl: S3-15; November, 2004.

  54. Saenger, R.; Maechler, G.; Potreck, M.; Zepp, F.; Knuf, M.; Habermehl, P.; Schuerman, L.  Booster Vaccination With Hexavalent DTPa-HBV-IPV/Hib Vaccine in the Second Year of Life Is As Safe As Concomitant DTPa-IPV/Hib + HBV Administered Separately. Vaccine; 23 (9): 1135-1143; January, 2005.

  55. Schutze, G. E.; Tucker, N. C.; Mason, E. O., Jr.  Impact of the Conjugate Pneumococcal Vaccine in Arkansas.   Pediatr Infect Dis J; 23 (12): 1125-1129; December, 2004.

  56. Schwartz, J. B.; Bhushan, I.  Improving Immunization Equity Through a Public-Private Partnership in Cambodia.   Bull World Health Organ; 82 (9): 661-667; September, 2004.

  57. Schweon, S. J.; Novatnack, E. S.  Fighting the Flu in the Face of a Shortage.   RN; 67 (12): 26-30; December, 2004.

  58. Sejvar, J.; Boneva, R.; Lane, J. M.; Iskander, J.  Severe Headaches Following Smallpox Vaccination.   Headache; 45 (1): 87-88; January, 2005. VAERS

  59. Sewell, W. A.  CCVID Patients May Not Respond to Influenza Immunization.   Clin Immunol; 114 (2): 210; February, 2005.

  60. Sikora, A.  [Safety of Vaccination in Connective Tissue Diseases]. Pol Arch Med Wewn; 112 (2): 1003-1008; August, 2004.

  61. Skowronski, D. M.; Bjornson, G.; Husain, E.; Metzger, D. L.; Scheifele, D. W.  Oculorespiratory Syndrome After Influenza Immunization in Children.   Pediatr Infect Dis J; 24 (1): 63-69; January, 2005.

  62. Steyer, T. E.; Mainous, A. G., III; Geesey, M. E.  The Effect of Race and Residence on the Receipt of Childhood Immunizations: 1993-2001. Vaccine; 23 (12): 1464-1470; February 10, 2005.

  63. Swart, B.  New Funding for Immunization in Canada.   Can Nurse; 100 (8): 14-15; October, 2004.

  64. Tabira, T.  [Vaccination Therapy for Alzheimer's Disease].   Nippon Ronen Igakkai Zasshi; 41 (6): 579-581; November, 2004.

  65. Triau, R.; Merieux, C.  [Against Meningococcus: a New Form of Vaccination].   Bull Acad Natl Med; 163 (3): 277-288; March, 1979.

  66. Valdespino-Gomez, J. L.; Garcia-Garcia, Mde L.  [Thirtieth Anniversary of the National Measles Vaccination Program in Mexico. The Great Benefits and Potential Risks].   Gac Med Mex; 140 (6): 639-641; November, 2004.

  67. Veirum, J. E.; Sodemann, M.; Biai, S.; Jakobsen, M.; Garly, M. L.; Hedegaard, K.; Jensen, H.; Aaby, P.  Routine Vaccinations Associated With Divergent Effects on Female and Male Mortality at the Paediatric Ward in Bissau, Guinea-Bissau.   Vaccine; 23 (9): 1197-1204; January, 2005.

  68. Vines, J.  [Smallpox Vaccinations in Navarre (Spain) Between September and November 1801.].   An Sist Sanit Navar; 27 (3): 359-371; September, 2004.

  69. Walker, D.; Mosqueira, N. R.; Penny, M. E.; Lanata, C. F.; Clark, A. D.; Sanderson, C. F.; Fox-Rushby, J. A.  Variation in the Costs of Delivering Routine Immunization Services in Peru.   Bull World Health Organ; 82 (9): 676-682; September, 2004.

  70. Waters, H. R.; Dougherty, L.; Tegang, S. P.; Tran, N.; Wiysonge, C. S.; Long, K.; Wolfe, N. D.; Burke, D. S.  Coverage and Costs of Childhood Immunizations in Cameroon.   Bull World Health Organ; 82 (9): 668-675; September, 2004.

  71. Weller, S.; Reynaud, C. A.; Weill, J. C.  Vaccination Against Encapsulated Bacteria in Humans: Paradoxes.   Trends Immunol; 26 (2): 85-89; February, 2005.

  72. Weycker, D.; Edelsberg, J.; Elizabeth, Halloran M.; Longini, I. M., Jr.; Nizam, A.; Ciuryla, V.; Oster, G.  Population-Wide Benefits of Routine Vaccination of Children Against Influenza.   Vaccine; 23 (10): 1284-1293; January 26, 2005.

  73. Winstock, A. R.  High Risk Groups Are Still Not Being Vaccinated. BMJ; 330 (7484): 198; January 22, 2005.

  74. Yameogo, K. R.; Perry, R. T.; Yameogo, A.; Kambire, C.; Konde, M. K.; Nshimirimana, D.; Kezaala, R.; Hersh, B. S.; Cairns, K. L.; Strebel, P.  Migration As a Risk Factor for Measles After a Mass Vaccination Campaign, Burkina Faso, 2002{Dagger}.   Int J Epidemiol; January, 2005. [Epub ahead of print]

  75. Zhang, Y.; Auranen, K.; Eichner, M.  The Influence of Competition and Vaccination on the Coexistence of Two Pneumococcal Serotypes. Epidemiol Infect; 132 (6): 1073-1081; December, 2004.